These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. Torella M, Del Deo F, Grimaldi A, Iervolino SA, Pezzella M, Tammaro C, Gallo P, Rappa C, De Franciscis P, Colacurci N. Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():125-128. PubMed ID: 27838537 [Abstract] [Full Text] [Related]
31. A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis. Tutolo M, Ammirati E, Castagna G, Klockaerts K, Plancke H, Ost D, Van der Aa F, De Ridder D. Int Braz J Urol; 2017 Feb; 43(1):134-141. PubMed ID: 28124536 [Abstract] [Full Text] [Related]
32. Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal reflux. Palmieri B, Merighi A, Corbascio D, Rottigni V, Fistetto G, Esposito A. Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3272-8. PubMed ID: 24379055 [Abstract] [Full Text] [Related]
33. Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. Lipovac M, Kurz C, Reithmayr F, Verhoeven HC, Huber JC, Imhof M. Int J Gynaecol Obstet; 2007 Mar; 96(3):192-5. PubMed ID: 17280667 [Abstract] [Full Text] [Related]
39. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease. Damiano R, Cicione A. Ther Adv Urol; 2011 Oct; 3(5):223-32. PubMed ID: 22046200 [Abstract] [Full Text] [Related]